首页 国际期刊 医学期刊 期刊详情(非官网)
400-808-1701

Journal Of Gastrointestinal And Liver Diseases

Journal Of Gastrointestinal And Liver Diseases杂志,由Romanian Society of Gastroenterology出版,于2006年创刊,Quarterly,出版语言English,ISSN:1841-8724,E-ISSN:1842-1121。

投稿咨询
Journal Of Gastrointestinal And Liver Diseases
Journal Of Gastrointestinal And Liver Diseases
Journal Of Gastrointestinal And Liver Diseases
SCI SCIE

杂志介绍

JCR分区
Q3
中科院分区
4区
影响因子
2.5
CiteScore
3
期刊收录
SCI、SCIE

Journal Of Gastrointestinal And Liver Diseases(中文译名:《胃肠和肝脏疾病杂志》),ISSN:1841-8724,EISSN:1842-1121,是Romanian Society of Gastroenterology出版的国际性学术期刊,创刊于2006年,以Quarterly形式稳定发行,2026年总发文量约56篇。该刊采用非OA开放访问,学科归属为医学 - 胃肠肝病学。该刊是医学、胃肠肝病学领域的国际权威刊物,已被SCI(科学引文索引)、SCIE(科学引文索引扩展版)等国际主流学术数据库收录。2026年期刊影响因子达2.5,2025年期刊CiteScore为3,2025年期刊自引率约4%,在中科院期刊分区体系中位列医学大类4区,在所属学科领域具备高学术影响力与国际认可度。Journal Of Gastrointestinal And Liver Diseases长期聚焦医学、胃肠肝病学及相关产业的技术应用前沿,平均审稿周期较慢,6-12周,审稿流程高效稳定。在稿件录用评判中,该刊将创新性与前沿性作为核心遴选标准,重点收录能够对医学、胃肠肝病学领域的落地与发展产生实质性推动价值的研究成果。

从全球发文格局来看,RomaniaItaly、GERMANY (FED REP GER)、USA、Japan、CHINA MAINLAND、England等为核心发文国家与地区;IULIU HATIEGANU UNIVERSITY OF MEDICINE & PHARMACYCAROL DAVILA UNIVERSITY OF MEDICINE & PHARMACY、REGIONAL INSTITUTE OF GASTROENTEROLOGY & HEPATOLOGY、INSTITUTUL CLINIC FUNDENI、ASL BAT、GRIGORE T POPA UNIVERSITY OF MEDICINE & PHARMACY、UNIVERSITY OF BOLOGNA等高校与科研机构是期刊的主要发文单位。

期刊评价

名词解释:

影响因子(Impact Factor, IF):指该期刊前两年发表的文章,在第三年的平均被引用次数。它反映了期刊的近期平均影响力和热度。

中科院分区:中科院分区表是国内主流的学术期刊分级评价工具,核心意义是建立跨学科可比的统一评价标尺,为职称评审、学位授予、科研立项等科研管理工作提供标准化量化依据,同时帮助科研人员筛选优质期刊、规避学术风险,适配国内本土化的科研评价需求。

期刊分区表

《新锐期刊分区表》(2026年3月发布)

大类学科 小类学科 Top期刊 综述期刊
医学
4区
GASTROENTEROLOGY & HEPATOLOGY 胃肠肝病学
4区

期刊分区表(2025年3月升级版)

大类学科 小类学科 Top期刊 综述期刊
医学
4区
GASTROENTEROLOGY & HEPATOLOGY 胃肠肝病学
4区

期刊分区表(2023年12月升级版)

大类学科 小类学科 Top期刊 综述期刊
医学
4区
GASTROENTEROLOGY & HEPATOLOGY 胃肠肝病学
4区

JCR分区

2025-2026年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:GASTROENTEROLOGY & HEPATOLOGY SCIE Q3 85 / 153

44.8

学科:GASTROENTEROLOGY & HEPATOLOGY SCIE Q3 102 / 153

33.66

2024-2025年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:GASTROENTEROLOGY & HEPATOLOGY SCIE Q3 94 / 148

36.8

学科:GASTROENTEROLOGY & HEPATOLOGY SCIE Q3 99 / 148

33.45


中国学者近期发文

1
Knockdown of EFEMP1 Promotes Ferroptosis by Inactivating PI3K/AKT to overcome the Resistance of Hepatocellular Carcinoma Cells to Sorafeni

Author:Zhou, Ti; Lan, Haibin; Ma, Yao; Fang, Donglin

Journal: JOURNAL OF GASTROINTESTINAL AND LIVER DISEASES. 2026; Vol. 35, Issue 1, pp. -. DOI: 10.15403/jgld-6499

2
A Rare Case Report of Primary Hepatic Lymphoma Complicated by Hemophagocytic Lymphohistiocytosi

Author:Zhang, Yu; Xun, Linting; Luo, Lilin; Wang, Shaobo; Liu, Airu

Journal: JOURNAL OF GASTROINTESTINAL AND LIVER DISEASES. 2026; Vol. 35, Issue 1, pp. -. DOI: 10.15403/jgld-6515

3
Successful treatment by hemostatic powder spray for massive gastrointestinal bleeding in an elderly male with duodenocolic fistul

Author:Yang, Shengye; Gao, Yanhong; Zheng, Xiaoyu; Qi, Xingshun

Journal: JOURNAL OF GASTROINTESTINAL AND LIVER DISEASES. 2026; Vol. 35, Issue 1, pp. -. DOI: 10.15403/jgld-6473

4
Future Global Outlook in Gastrointestinal and Liver Disorders: Consensus and Perspectives from the Leaders of Member Societies of the World Gastroenterology Organizatio

Author:Tagiling, Nashrulhaq; Simadibrata, Daniel M.; Makharia, Govind K.; Sadgehi, Anahita; Moreira, Leticia; Leung, Wai K.; Kaplan, Gilaad G.; Leddin, Desmond; Metz, Geoffrey; Barkun, Alan N.; Lee, Yeong Yeh

Journal: JOURNAL OF GASTROINTESTINAL AND LIVER DISEASES. 2026; Vol. 35, Issue 1, pp. -. DOI: 10.15403/jgld-7010

5
Programmed Cell Death-ligand 1 as Biomarker of Poor Prognosis in Patients with Gastrointestinal Stromal Tumou

Author:Yasheng, Duolikun; Aierken, Abuduwaili; Li, Yiliang; Aili, Aikebaier; Abudureyimu, Kelimu

Journal: JOURNAL OF GASTROINTESTINAL AND LIVER DISEASES. 2025; Vol. 34, Issue 1, pp. 30-39. DOI: 10.15403/jgld-5858

6
Association of ABCB6 Polymorphisms and Serum Levels with Susceptibility to Antituberculosis Drug-induced Hepatotoxicit

Author:Chen, Ruina; Cheng, Jingru; Pan, Hongqiu; Lu, Lihuan; He, Xiaomin; Zhang, Meiling; Yi, Honggang; Tang, Shaowen

Journal: JOURNAL OF GASTROINTESTINAL AND LIVER DISEASES. 2025; Vol. 34, Issue 1, pp. 55-63. DOI: 10.15403/jgld-5892

7
Nucleolin as a Potent Biomarker for Predicting Tumor Recurrence among Patients with Hepatocellular Carcinoma after Transplantatio

Author:Chen, Guanrong; Hu, Xin; Huang, Yingchen; Li, Huigang; Dong, Libin; Jiang, Yao; Lu, Di; Jiang, Feng; Li, Xiuyang; Sun, Beicheng; Zheng, Shusen; Lang, Ren; Xu, Xiao; Chen, Ronggao

Journal: JOURNAL OF GASTROINTESTINAL AND LIVER DISEASES. 2025; Vol. 34, Issue 1, pp. 81-89. DOI: 10.15403/jgld-5873

8
The Mediation Effects of Type 2 Diabetes Mellitus and Related Biomarkers on the Association of Metabolic Dysfunction-associated Steatotic Liver Disease and Fibrosi

Author:Cai, Rujun; Liu, Zhenqiu; Fan, Hong; Zhang, Xin; Chen, Yizhou; Zhang, Tiejun

Journal: JOURNAL OF GASTROINTESTINAL AND LIVER DISEASES. 2025; Vol. 34, Issue 1, pp. 47-54. DOI: 10.15403/jgld-5901


在线咨询

Journal Of Gastrointestinal And Liver Diseases

国际简称:J GASTROINTEST LIVER参考译名:胃肠和肝脏疾病杂志

年发文量:56 CiteScore:3 是否预警:否 Gold OA文章占比:100.00% 研究类文章占比:69.64%

杂志社联系方式:MEDICAL UNIV PRESS, 3RD MEDICAL CLINIC, STR CROITORILOR NO 19-21, CLUJ-NAPOCA, ROMANIA, 400162

Journal Of Gastrointestinal And Liver Diseases